Skip to content

BIOSURE™ HEALICOIL™ PK Bone In-growth Study

A Radiographic Study of Patients Treated With the BIOSURE™ HEALICOIL™ PK Interference Screw for ACL Repair With Soft Tissue Fixation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02382341
Enrollment
12
Registered
2015-03-06
Start date
2014-09-12
Completion date
2017-01-04
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deficiency of Anterior Cruciate Ligament

Keywords

ACL, BIOSURE, HEALICOIL, PEEK, In-Growth

Brief summary

The study seeks to document the bone in-growth into the BIOSURE™ HEALICOIL PK screw as measured by CT scans. Patients' improvement in pain and function will also be followed through various outcome measures.

Detailed description

The primary objective of the current study is to assess bone in-growth in the BIOSURE™ HEALICOIL™ Interference screw in the tibial tunnel of patients undergoing ACL reconstruction with soft tissue grafts; tunnel widening and change in IKDC knee and subjective scores will also be documented.

Interventions

DEVICEBIOSURE™ HEALICOIL™ PK Interference Screw

Subjects will receive the appropriate sized BIOSURE™ HEALICOIL™ PK Interference Screw

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* ACL tear requiring surgical reconstruction with semitendinosus/gracilis graft. * Willing and able to give voluntary informed consent to participate in this study * Willing and able, in the opinion of the investigator, to cooperate with study procedures and willing to return to study site for all post-operative study visits. * Subject is between 18 and 50 years at the time of surgery * ASA group 0-2 (limited medical illness).

Exclusion criteria

* Revision ACL reconstruction * Cartilage injury (IKDC Grade IV lesion\> 2 cm2) * Current malignant disease * Rheumatoid arthritis * Osteonecrosis or Avascular Necrosis * Ankylosing spondylitis * Subject is Obese; BMI \> 35 * Subject is pregnant or plans to become pregnant during the study * Subject has received medical treatment within 6 weeks of enrollment with any of the following: Glucocorticoids Growth hormone * Participating in another investigational trial or on-going study that would interfere with the assessment of the primary and secondary outcomes

Design outcomes

Primary

MeasureTime frameDescription
Bone In-growth measured by CT scans1 yearBone In-growth measured by CT scans

Secondary

MeasureTime frameDescription
Bone In-growth measured by CT scans6 monthsBone In-growth measured by CT scans
Improvement in IKDC Knee Examination scoring from baseline to 1 year post-operatively1 year
Improvement in the IKDC Subjective Knee Evaluation scoring from baseline to 1 year post-operatively1 year
Improvement in IKDC Knee Examination scoring from baseline to 2 years post-operatively2 years
Improvement in the IKDC Subjective Knee Evaluation scoring from baseline to 2 years post-operatively2 Years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026